BIOMAT Database Logo BIOMAT Database Logo

[EFFECT OF LEVOMYCETIN ON THE GROWTH OF DYSENTERY CULTURES]. 1964

F K CHERKES, and Z N SPASSKAIA, and A K SUPRANIUK, and R I MONOSZON, and N I FROLOVA

UI MeSH Term Description Entries
D010600 Pharmacology The study of the origin, nature, properties, and actions of drugs and their effects on living organisms. Pharmacologies
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D002701 Chloramphenicol An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004403 Dysentery Acute inflammation of the intestine associated with infectious DIARRHEA of various etiologies, generally acquired by eating contaminated food containing TOXINS, BIOLOGICAL derived from BACTERIA or other microorganisms. Dysentery is characterized initially by watery FECES then by bloody mucoid stools. It is often associated with ABDOMINAL PAIN; FEVER; and DEHYDRATION. Infectious Diarrheal Disease,Diarrheal Disease, Infectious,Infectious Diarrheal Diseases
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D012760 Shigella A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that ferments sugar without gas production. Its organisms are intestinal pathogens of man and other primates and cause bacillary dysentery (DYSENTERY, BACILLARY).
D012764 Shigella sonnei A lactose-fermenting bacterium causing dysentery. Bacterium sonnei

Related Publications

F K CHERKES, and Z N SPASSKAIA, and A K SUPRANIUK, and R I MONOSZON, and N I FROLOVA
[Effect of chlortetracycline and levomycetin therapy on riboflavin balance in dysentery].
January 1957, Antibiotiki,
F K CHERKES, and Z N SPASSKAIA, and A K SUPRANIUK, and R I MONOSZON, and N I FROLOVA
[On the effect of levomycetin resistant Flexner dysentery bacteria on the development of postinfection immunity].
January 1966, Antibiotiki,
F K CHERKES, and Z N SPASSKAIA, and A K SUPRANIUK, and R I MONOSZON, and N I FROLOVA
[EFFECT OF LEVOMYCETIN ON THE SYNTHESIS OF NUCLEIC ACIDS AND PROTEINS BY DYSENTERY BACTERIA].
December 1963, Antibiotiki,
F K CHERKES, and Z N SPASSKAIA, and A K SUPRANIUK, and R I MONOSZON, and N I FROLOVA
[Levomycetin therapy of dysentery in children].
January 1952, Pediatriia,
F K CHERKES, and Z N SPASSKAIA, and A K SUPRANIUK, and R I MONOSZON, and N I FROLOVA
[Effect of streptomycin, biomycin and levomycetin on group B vitamin synthesis by dysentery bacteria].
January 1965, Mikrobiolohichnyi zhurnal,
F K CHERKES, and Z N SPASSKAIA, and A K SUPRANIUK, and R I MONOSZON, and N I FROLOVA
[On the incidence of detection of carriers of levomycetin-resistant dysentery bacilli].
September 1965, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
F K CHERKES, and Z N SPASSKAIA, and A K SUPRANIUK, and R I MONOSZON, and N I FROLOVA
[Result of application of levomycetin in the treatment of dysentery].
March 1955, Klinicheskaia meditsina,
F K CHERKES, and Z N SPASSKAIA, and A K SUPRANIUK, and R I MONOSZON, and N I FROLOVA
[Effect of levomycetin on spermatogenesis].
January 1958, Urologiia (Moscow, Russia : 1923),
F K CHERKES, and Z N SPASSKAIA, and A K SUPRANIUK, and R I MONOSZON, and N I FROLOVA
[Effect of levomycetin on immunological indices in rabbits immunized with living cultures of Flexner bacillus].
January 1956, Antibiotiki,
F K CHERKES, and Z N SPASSKAIA, and A K SUPRANIUK, and R I MONOSZON, and N I FROLOVA
[CLINICO-IMMUNOLOGIC COMPARATIVE STUDIES ON LEVOMYCETIN THERAPY OF TYPHOID ACUTE DYSENTERY AND OF CHRONIC DYSENTERY CARRIERS AND TYPHOID CARRIERS].
November 1964, Sovetskaia meditsina,
Copied contents to your clipboard!